Similar articles

• Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.

  Clayton AH, Baker RA, Sheehan JJ, Cain ZJ, Forbes RA, Marler SV, Marcus R, Berman RM, Thase ME. Clayton AH, et al. BMC Res Notes. 2014 Jul 18;7:459. doi: 10.1186/1756-0500-7-459. BMC Res Notes. 2014. PMID: 25037144 Free PMC article. Clinical Trial.
• Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.

  Strawn JR, Mills JA, Croarkin PE. Strawn JR, et al. J Child Adolesc Psychopharmacol. 2019 May;29(4):250-255. doi: 10.1089/cap.2018.0145. Epub 2019 Feb 27. J Child Adolesc Psychopharmacol. 2019. PMID: 30810350 Free PMC article.
• Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic index.

  Pilotto A, D'Onofrio G, Panza F, Copetti M, Cascavilla L, Paris F, Pellegrini F, Seripa D, Ferrucci L. Pilotto A, et al. J Clin Psychopharmacol. 2012 Oct;32(5):726-9. doi: 10.1097/JCP.0b013e31826866bd. J Clin Psychopharmacol. 2012. PMID: 22926617 No abstract available.
• Escitalopram (Lexapro) for depression.

  Masilamani S, Ruppelt SC. Masilamani S, et al. Am Fam Physician. 2003 Dec 1;68(11):2235-6. Am Fam Physician. 2003. PMID: 14677669 Review.
• Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

  Papakostas GI, Nutt DJ, Hallett LA, Tucker VL, Krishen A, Fava M. Papakostas GI, et al. Biol Psychiatry. 2006 Dec 15;60(12):1350-5. doi: 10.1016/j.biopsych.2006.06.015. Epub 2006 Aug 24. Biol Psychiatry. 2006. PMID: 16934768 Review.